Global Organ-on-Chip Market Size To Worth USD 199.31 Million By 2033 l CAGR of 13.12%
Category: HealthcareGlobal Organ-on-Chip Market Size To Worth USD 199.31 Million By 2033
According to a research report published by Spherical Insights & Consulting, the Global Organ-on-Chip Market Size is to Grow from USD 58.08 Million in 2023 to USD 199.31 Million by 2033, at a Compound Annual Growth Rate (CAGR) of 13.12% during the projected period.
Get more details on this report -
Browse key industry insights spread across 257 pages with 110 Market data tables and figures & charts from the report on the "Global Organ-on-Chip Market Size, Share, and COVID-19 Impact Analysis, By Application (Disease Modeling, Drug Discovery, and Toxicity Testing), By Organ Type (Lungs, Heart, Liver, and Kidney), By End-Users (Pharmaceuticals and Biotech Companies, Contract Research Organizations, and Academic & Research Institutes) and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033" Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/organ-on-chip-market
Organ-on-a-chips are micro-engineered biomimetic systems that mimic the form and function of human tissue. Small devices containing human cells are used to imitate the environment of human organs, such as blood flow and respiratory motions, as well as synthetic habitats for testing new drugs. Organ-on-a-chip technologies can overcome the limitations of standard two-dimensional cell culture methods, enabling for the development of models that more accurately mimic the three-dimensional arrangement of distinct cell types. The market driven by the necessity for substitutes to animal testing, as well as the prompt identification of pharmaceutical reactions and toxicity. In addition, organ-on-chip technology is not limited to the liver, lungs, kidneys, or heart. Stakeholders in this market are doing their utmost to expand the organ's applications and sites utilizing this technology. However, the organ-on-chip industry is projected to face challenges from stringent regulations during the forecast period.
The drug discovery category is likely to promote market growth during the forecast period.
Based on the application, the organ-on-chip market is divided into disease modeling, drug discovery, and toxicity testing. Among these, the drug discovery category is likely to promote market growth during the forecast period. Organ-on-chip technology has contributed to drug discovery by providing more biologically realistic models of human organ function and interaction than traditional in vitro and animal models. These microscale platforms enable investigators to study therapeutic efficacy, toxicity, and safety more accurately and cost-effectively, reducing drug development time and the probability of late-stage failures in clinical trials. This market benefits from the increased demand for novel research methodologies and technologies capable of identifying promising drug candidates more effectively and precisely.
The liver organ type is expected to dominate the market over the projection period.
Based on organ type, the organ-on-chip market is divided into lungs, heart, liver, and kidney. Among these, the liver organ type is expected to dominate the market over the projection period. Liver-on-chip platforms have several advantages over traditional techniques, including improved predictability, less reliance on animal testing, and the ability to screen drug candidates in large quantities. Liver-on-chip models are used to imitate physiological settings, including toxicity testing and disease modeling. It is one of the largest R&D platforms, with a diverse range of commercial products accessible on the market. Liver-on-chip platforms are utilized for a wide range of applications, including drug discovery, toxicity testing, disease modeling, and personalized medicine, which account for a significant percentage of the medical market.
The pharmaceutical and biotech company is expected to have the biggest market share during the forecast period.
Based on end-users, the organ-on-chip market is divided into pharmaceuticals and biotech companies, contract research organizations, and academic & research institutes. Among these, the pharmaceutical and biotech company is expected to have the biggest market share during the forecast period. Pharmaceutical and biotechnology firms are the main end-users in the organ-on-chip market, given their enormous investment in R&D operations targeted at identifying and creating new drugs and treatments. These businesses provide resources, expertise, and facilities to support research and development of breakthrough healthcare solutions. Furthermore, these companies collaborate with universities, educational research institutions, and contract research organizations (CROs) to evaluate and optimize organ-on-chip technology, resulting in faster uptake and deployment in the pharmaceutical sector.
North America is expected to have the greatest share of the global organ-on-chip market during the forecast period.
Get more details on this report -
North America is expected to have the greatest share of the global organ-on-chip market during the forecast period. North America has historically been the largest market for organ-on-chip technology. It is the primary place for the deployment of this technology because of the presence of various pharmaceutical companies, research organizations, and technology developers. This site provides a favorable atmosphere for biotech and life science research, encouraging new breakthroughs. Regulatory agencies, such as the FDA, collaborate with stakeholders to study possible applications in pharmaceutical discovery and safety review.
Asia Pacific is predicted to experience the fastest CAGR growth in the global organ-on-chip market during the forecast period. Increased demand for personalized medications, expansion of medical facilities, and the presence of a large pharmaceutical market all contribute to its place as the fastest-growing market.
Major vendors in the organ-on-chip market include SynVivo, Cherry Biotech, InSphero AG, Elveflow, Ascendance Biotechnology, Inc., Draper, Mimica, Zyoxel Ltd., AxoNet Medical Systems, Inc., AxoSim Technologies, Nortis, Inc., Mimetas, MIMETAS B.V., Tara Biosystems, Kirkstall Ltd., and others.
Recent Developments
- In June 2023, Emulate introduced Emulate Chip-A1 to broaden its applications in oncology and cosmetics.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global organ-on-chip market based on the below-mentioned segments:
Global Organ-on-Chip Market, By Application
- Disease Modeling
- Drug Discovery
- Toxicity Testing
Global Organ-on-Chip Market, By Organ Type
- Lungs
- Heart
- Liver
- Kidney
Global Organ-on-Chip Market, By End-Users
- Pharmaceuticals and Biotech Companies
- Contract Research Organizations
- Academic & Research Institutes
Global Organ-on-Chip Market, By Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?